IV Heparin for Unstable Angina
Yes, you should start IV heparin for a patient admitted with unstable angina as it is considered a fundamental Class IA therapy when given in conjunction with antiplatelet agents. 1
Rationale for IV Heparin in Unstable Angina
Heparin plays a critical role in the management of unstable angina by:
- Preventing acute myocardial infarction and recurrent angina 1
- Reducing the incidence of refractory angina (from 22.9% to 8.5%) 1
- Decreasing fatal and non-fatal MI when used in combination with aspirin by approximately 30% 1
Studies have demonstrated that heparin is highly effective in preventing acute MI, with one study showing reduction in MI incidence from 11.9% in placebo to just 0.8% in the heparin group 1.
Dosing Recommendations
For unstable angina, follow this dosing protocol:
- Initial bolus: 60-70 U/kg (maximum 5000 U) IV 1
- Maintenance infusion: 12-15 U/kg/hour 1
- Target aPTT: 50-70 seconds (approximately 1.5-2.0 times control value) 1, 2
Monitor aPTT at 6 hours after initiation and adjust according to results. Studies show that with standard regimens, 25% of patients may be subtherapeutic at 6 hours 3.
Duration of Therapy
Continue IV heparin for at least 48 hours after admission. Evidence suggests that:
- Optimal duration is up to 48 hours 4
- Longer therapy (>48 hours) has been associated with increased adverse consequences 4
- Continue for the duration of hospitalization, up to 8 days, if medical therapy is selected as post-angiography management 1
Combination with Other Therapies
Always use heparin in combination with:
Monitoring and Adjustments
Check aPTT at 6 hours and 12 hours after initiation 3
Adjust dose according to aPTT results:
- If aPTT <35 seconds: Give 80 units/kg bolus and increase infusion by 4 units/kg/hour 5
- If aPTT 35-45 seconds: Give 40 units/kg bolus and increase by 2 units/kg/hour 5
- If aPTT 46-70 seconds: No change (therapeutic range) 5
- If aPTT 71-90 seconds: Reduce infusion by 2 units/kg/hour 5
- If aPTT >90 seconds: Stop infusion for 1 hour, then reduce by 3 units/kg/hour 5
Monitor platelet counts regularly between days 4-14 to detect heparin-induced thrombocytopenia 5
Potential Complications and Precautions
- Bleeding risk: Major bleeding occurs in approximately 1.9% of patients 1
- Heparin-induced thrombocytopenia: Risk is higher with unfractionated heparin (up to 5%) compared to LMWH 5
- Contraindications: Active major bleeding, severe thrombocytopenia, known hypersensitivity to heparin 2
Alternative Options
If heparin is contraindicated or if you prefer an alternative:
- Low molecular weight heparin (enoxaparin): May be preferable to unfractionated heparin unless CABG is planned within 24 hours 1
- Fondaparinux: Consider if no PCI is planned within 24 hours 1
- Bivalirudin: Consider especially if PCI is planned 1
Transitioning from Heparin
When transitioning from heparin to oral anticoagulants:
- For warfarin: Continue full heparin therapy until INR reaches stable therapeutic range 2
- For other oral anticoagulants: Stop IV heparin immediately after administering first dose 2
Remember that the combination of aspirin and heparin has shown superior outcomes compared to either agent alone in unstable angina patients, making IV heparin an essential component of treatment.